Research Results: What Was Measured?
An interactive guide to reported cell-culture and animal-model outcomes, distinguishing measured endpoints, interpretation and proposed mechanism. Full protocol and sample-level details may be requested from the research team.
100% survival of virus-infected mice in the tested experimental groups
Result from the 2006 cinnamon extract study; see the protocol below.
How was mouse survival measured?Figures are shown in the context of the reported experiment. This page does not replace raw data, a statistical report or a full methods section. Explore the survival experiment ↓
Research endpoints at a glance
Cell culture
The 2006 document describes cinnamon-extract and extract-fraction assays, including protection of Vero cells against HSV-1 cytopathic effects and hemolysis-related assays for influenza viruses. These endpoints are not necessarily equivalent to direct PFU/ml counts.
See the study and endpointAnimal model
Figures 9–11 report body-weight changes, mortality and survival in mouse groups. Example 9 describes zero deaths among 10 mice given virus pre-exposed to extract.
See the study and endpointProposed mechanism
Galoz Kaneti’s 2020 APA-013 disclosure describes Ceylon cinnamon oil-and-water formulations, surfactants, preparation approaches and emulsion observations. Results from the 2006 extract cannot automatically be attributed to every later CVT formulation.
See the methodologyWhat does the experiment actually measure?
Select a stage to distinguish experimental setup, readout and interpretation. This schematic does not introduce new data.
Original schematic • not raw experimental data or a microscope image
In vivo experiment detail
100% survival is a result from a defined experimental group—not a general claim across viruses, studies or formulations.
10 of 10 mice survived
Example 9 reports no deaths in the group where influenza virus was pre-exposed to cinnamon extract. Each group contained 10 mice.
Mortality and change in body weight during follow-up
Weight loss and deaths were reported in virus-only control groups.
Example 11 — post-exposure (Fig. 14A–B)
Mice were exposed to Sendai virus and received CE ppt after exposure, immediately or one hour later. Body weight was monitored.
Example 12 — administration routes (Fig. 14C–D)
Mice previously given a virus–extract mixture through different routes were challenged again. Changes in body weight were assessed.
Virus-by-virus evidence map
Each virus is linked to a documented assay. Where no matching primary record is included in the provided materials, this is shown explicitly.
HSV-1
- Documented assay
- Vero-cell assay; cytopathic effect (CPE)
- Measured endpoint
- Cell effects during viral challenge
- Study source
- US20060275515A1 · Example 10
Influenza A
- Documented assay
- Hemolysis assays; mouse survival model
- Measured endpoint
- Hemolysis inhibition and protocol-specific survival
- Study source
- US20060275515A1 · Examples 1–2, 9
Sendai
- Documented assay
- Hemolytic assays; mouse weight follow-up
- Measured endpoint
- Hemolysis and post-exposure weight change
- Study source
- US20060275515A1 · Examples 1–2, 11
Rotavirus
- Documented assay
- Described in the portal’s research materials
- Measured endpoint
- Matching primary protocol not included here
- Study source
- Further study record on request
Further assay records may be requested when the inquiry channel is active
How should the experimental findings be read?
The documents report different endpoints. They are informative side by side, but they cannot be converted into one common percentage without the underlying assay methods and calculations.
Key points for critical reading
Cell protection and cytopathic effect (CPE)
The HSV-1 Vero-cell experiment assessed how a cinnamon extract fraction affected visible virus-associated changes in cultured cells. This is a defined cellular endpoint—not automatically a direct particle count or a standardized viral titer.
Hemolysis assays
The Influenza A and Sendai experiments included measures of virus-associated red-cell hemolysis. Suppression of this readout is an assay-specific finding; it should not be relabeled as a PFU/ml reduction without an actual plaque assay.
Survival and body weight in mice
Animal experiments recorded mortality and weight changes under different protocols. The 10/10 figure refers to a specific group in which virus was exposed to the extract before administration, and should not be merged with post-exposure protocols.
Frequently asked questions
Does a strong cell-culture result prove efficacy in humans?
No. Cell culture is a controlled experimental model. Clinical benefit would require suitable human studies.
Did every mouse experiment show 100% survival?
No. Separate experiments reported different outcomes, including body weight, exposure after infection and route-of-administration comparisons.